|
Endocare is a pioneer in the development of cryoablation (freezing) technologies for the treatment of prostate cancer, as well as the ablation of tumors in the kidney, lung and liver. Cryoablation may also be used to manage bone pain resulting from metastatic cancer. The Cryocare system was originally cleared by the FDA in 1994 and the cryoablation procedure was approved by CMS for primary treatment of prostate cancer in July 1999. Since then, the company has committed itself to delivering innovative equipment, training, and techniques that improve the health and quality of patients' lives.
CODE OF CONDUCT & COMPLIANCE.
Endocare adheres to a formal Compliance Plan and Code of Conduct set forth by the Advanced Medical Technology Association (ADVAMED). Please read the links on this page regarding our compliance program and important disclaimer statements.
Endocare, Inc.
201 Technology Drive
Irvine, CA 92618
1-877-722-2796
www.endocare.com
|
|
